当前位置：首页 > 文献互助 > 互助详情

期刊论文Efficacy Analyses from the Immune Thrombocytopenia (ITP) Clinical Development Program for Avatrombopag: Comparisons with Placebo and Eltrombopag复制

用户zXqBMD2rfL_4 3个月前 147 已完结

1. 系统已在2025-03-27 16:17:39对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI: 10.1182/blood-2020-142788复制

文献链接: https://ashpublications.org/blood/article/136/Supplement%201/23/472347/Efficacy-Analyses-from-the-Immune-Thrombocytopenia复制

其他信息:

出版社: American Society of Hematology
作者: Michael D Tarantino; Michael Vredenburg; Wei Tian; Brian Jamieson; Kashyap B Patel
全文下载地址: https://ashpublications.org/blood/article/136/Supplement%201/23/472347/Efficacy-Analyses-from-the-Immune-Thrombocytopenia

上一篇：Genetic deficiency or pharmacological inhibition of cGAS–STING signalling suppresses kidney inflammation and fibrosis

下一篇：Crystal Engineering for Enhanced Solubility and Bioavailability of Poorly Soluble Drugs

互助时间线

2025-03-25 15:19:36 [完结求助]

系统完结了求助, 已自动确认了金木水火土应助的文件是正确的, 求助状态变成已完结

2025-03-20 16:17:39 [上传文件]

金木水火土上传了文件(pdf 774.45 KB), 求助状态变成待确认

2025-03-20 16:05:23 [驳回应助]

楼主驳回了你是我的星应助的文件, 求助状态回到求助中

备注: 这是全文么？感觉和网站上的内容一样多

2025-03-20 15:45:57 [上传文件]

你是我的星上传了文件(pdf 774.40 KB), 求助状态变成待确认

2025-03-20 15:19:36 [发起求助]

最新发布的求助

Echolocation over long distances 37分钟前

Nitroxide radical contrast agents for safe magnetic resonance imaging: progress, challenges, and perspectives 1小时前

Smart cities for emergency management 2小时前

Oral ENPP1 inhibitor designed using generative Al as next generation STiNG modulator for solid tumors 12小时前

癌患者の痛みに対する塩酸モルヒネ坐剤AN-631の有用性の検討－硫酸モルヒネ徐放錠との比較― 15小时前

癌患者の疼痛治療におけるAN-631H(塩酸モルヒネ坐剤30mg)の臨床評価 15小时前

Regulatory T cells in the tumour microenvironment 16小时前

POS0734 DAPIROLIZUMAB PEGOL 显示系统性红斑狼疮疾病活动有显着改善：疗效 ... 16小时前

Induction chemotherapy followed by camrelizumab plus apatinib and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, single-arm trial 17小时前

Neoadjuvant apatinib addition to sintilimab and carboplatin-taxane based chemotherapy in patients with early triple-negative breast cancer 17小时前

Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma 17小时前

Camrelizumab Plus Apatinib and Temozolomide as First-Line Treatment in Patients With Advanced Acral Melanoma 17小时前